Lotus Eye Hospital & Institute's Q1 2024 financials show neutral performance with positive cash flow and sales growth.

Aug 13 2024 02:00 PM IST
share
Share Via
Lotus Eye Hospital & Institute, a microcap healthcare services company, has reported a flat performance in the quarter ending March 2024. However, the company's operating cash flow has been the highest in the last three years, indicating strong cash revenues. Net sales have also shown a positive trend, but PAT has declined. Investors should consider these factors before investing.

Lotus Eye Hospital & Institute, a microcap healthcare services company, has recently announced its financial results for the quarter ending March 2024. The company's stock has been given a 'Sell' call by MarketsMOJO.

According to the financial report, Lotus Eye Hospital has shown a flat performance in the quarter of June 2024. However, there has been an improvement in the company's score from -10 to 0 in the last three months.

One of the positive aspects of the company's financials is its operating cash flow, which has been the highest at Rs 5.68 crore in the last three years. This indicates that the company has been able to generate higher cash revenues from its business operations.

In terms of net sales, Lotus Eye Hospital has also shown a positive trend with the highest quarterly sales of Rs 12.89 crore in the last five quarters.

However, the company's profit after tax (PAT) for the nine-month period has seen a decline of -58.93% year on year, standing at Rs 1.31 crore. This indicates a negative trend in the near term for the company's PAT.

Overall, Lotus Eye Hospital & Institute's financial performance for the quarter ending March 2024 has been neutral, with some positive and negative aspects. Investors are advised to take note of these factors before making any investment decisions.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News